Gelomics is an Australian company founded in 2018. Our mission is to provide the research community with the highest quality 3D cell culture technology at affordable prices. Our products are manufactured to industrial standards using validated protocols and enable reproducible studies with outstanding predictive value.

Dr Christoph Meinert

Managing Director

Dr Christoph Meinert completed his PhD in Bioengineering from the Queensland University of Technology in 2017. In addition to his expertise in hydrogel cultures that span many different cell types, Christoph has led the development of key technologies that enable 3D cell culture. 

Dr Peter Levett


Dr Peter Levett completed his joint PhD from Queensland University of Technology and University Medical Centre Utrecht in 2016. His work on photocrosslinkable hydrogels has been influential in the tissue engineering field.

Associate Professor

Travis Klein


A/Prof Travis Klein earned his PhD in bioengineering from the University of California, San Diego (UCSD) in 2005. His hydrogel experience goes back to the early days of his PhD, with alginate, and he has continued working with a range of hydrogels since then with his students and post-doctoral researchers. 

Distinguished Professor

Dietmar W. Hutmacher


D/Prof Dietmar W. Hutmacher is a biomedical engineer, educator, inventor, and creator of new intellectual property and entrepreneurial opportunities. He is a global leader in biomaterial science, biomedical and tissue engineering and regenerative medicine. D/Prof Hutmacher is one of few academics who translated a tissue engineering concept from bench to bedside.

Jordan Davern 

Production Manager

Hayley Zhang

Marketing Coordinator

Pawel Mieszczanek

Mechatronics Engineer

Aaron Foster

Mechatronics Engineer

Ross Kent


Tens of thousands of academic and industrial laboratories apply cell culture to study the biology of cells that regulate health and disease, to identify and develop new drugs, and even find ways to grow replacement tissues for implantation. But there is a major problem with the way cells are cultured in most laboratories. Cells are grown on flat, unphysiologically stiff materials such as polystyrene and glass, causing them to display aberrant behaviors: flattened shape, abnormal polarisation, altered response to pharmaceutical reagents, and general loss of phenotype. Although scientists agree that traditional cell culture methods fail to recapitulate the native cellular microenvironment, there is a lack of easy-to-use and widely applicable systems that are capable of recreating such environments in the laboratory while providing consistent properties from batch-to-batch.


LunaGel™ is a photocrosslinkable hydrogel cell culture system that recreates the natural extracellular matrix (ECM) surrounding cells in the human body, allowing researchers to grow three-dimensional microscopic tissues, rather than just cells on plastic surfaces. The major components of LunaGel™ include native ECM proteins such as collagen type I, III, IV, and V, as well as connective tissue glycoproteins and proteoglycans. LunaGel™ retains the intrinsic cell-instructive bioactivity of natural ECMs, facilitating cell attachment, proliferation, differentiation, migration, and proteolytic degradation.

Subscribe to download our white paper now!

Follow us


Contact info

Gelomics Pty Ltd

ABN: 14 624 623 623

1800 865 060


60 Musk Avenue

Kelvin Grove, QLD 4059


© Gelomics Pty Ltd, Brisbane, Australia

All rights reserved. For Research Use Only.

Not for use in diagnostic procedures.